Evidence map›Paper›PMID 40616729›Full record

ArticleInternational journal of hematology2025

Post-transplant changes in physical functioning and quality of life in patients undergoing two allogeneic hematopoietic stem cell transplants.

Takahiro Takekiyo, Yoshikiyo Ito, Takayoshi Miyazono, Masahito Tokunaga, Nobuaki Nakano, Jun Odawara, Satoshi Fujino, Koichiro Dozono, Soichiro Nara, Shuichiro Shimoyama and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Takahiro TakekiyoDepartment of Rehabilitation, Imamura General Hospital, 11-23 Kamoikeshinmachi, Kagoshima, 890-0064, Japan. soutakekiyo@yahoo.co.jp.ORCID http://orcid.org/0000-0002-8127-1878
Yoshikiyo ItoDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.
Takayoshi MiyazonoDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.
Masahito TokunagaDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.
Nobuaki NakanoDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.
Jun OdawaraDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.
Satoshi FujinoDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.
Koichiro DozonoDepartment of Rehabilitation Medicine, Imamura General Hospital, Kagoshima, Japan.
Soichiro NaraDepartment of Rehabilitation Medicine, Imamura General Hospital, Kagoshima, Japan.
Shuichiro ShimoyamaDepartment of Rehabilitation, Imamura General Hospital, 11-23 Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Toshiyuki OkamuraDepartment of Rehabilitation, Imamura General Hospital, 11-23 Kamoikeshinmachi, Kagoshima, 890-0064, Japan.
Atae UtsunomiyaDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study retrospectively examined changes in physical functioning and quality of life (QOL) in allogeneic hematopoietic stem cell transplantation (HSCT) recipients at their first (HSCT-1) and second (HSCT-2) transplantations. Seventeen patients who underwent HSCT-2 after relapse following HSCT-1 at our hospital between May 2013 and November 2023 and who underwent physical therapy evaluations before and after both transplantations were analyzed. Physical functioning was evaluated using handgrip strength as a measure of muscle strength, and exercise tolerance using the 6-min walk test (6MWT). QOL was assessed using the Medical Outcome Study 36-Item Short Form Health Survey (SF-36). Changes in physical functioning included handgrip strength (HSCT-1: - 9.3%; HSCT-2: - 18.3%; p < 0.05) and 6MWT findings (HSCT-1: - 5.1%; HSCT-2: - 12.6%; p < 0.05), which showed a significantly greater decline at HSCT-2. Physical functioning scores (SF-36) showed changes in QOL (HSCT-1: - 4.3 points; HSCT-2: - 23.4 points; p < 0.05), with a significantly greater reduction at HSCT-2. The findings indicate that the decline in physical functioning and QOL was more pronounced during the second transplantation than during the first. This highlights the importance of prioritizing strategies to maintain physical activity levels, particularly during the second transplantation process.

Indexed as

Hematopoietic Stem Cell TransplantationQuality of LifeAdultAllograftsExercise ToleranceFemaleHand StrengthHumansMaleMiddle AgedRetrospective StudiesTransplantation, HomologousExercise therapyPhysical functioning changeQuality of lifeSecond allogeneic hematopoietic stem cell transplantation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.